Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
American Journal of Therapeutics(3)
Revista Latinoamericana de Hipertension(2)
Archivos Venezolanos de Farmacologia y Terapeutica(1)
Revista de Salud Publica(1)
Área temáticas
Enfermedades(6)
Fisiología humana(3)
Farmacología y terapéutica(2)
Medicina y salud(2)
Bioquímica(1)
Chlamydia trachomatis infection in females consulting health centres in Maracaibo, Venezuela
ArticleAbstract: Objective Evaluating Chlamydia trachomatis infection prevalence in a group of symptomatic and asymptPalabras claves:Cervicitis, Chlamydia trachomatis, gynaecologyAutores:Arráiz N., Colina S., Marcucci R., Reyes F., Reyna-Villasmil N., Rondón N., Valmore BermúdezFuentes:scopusAbnormally high lipoprotein(a) levels in African-American communities from venezuela faced to other african-descending populations: Are ethnic origins related?
ArticleAbstract: Objective. Lipoprotein(a) is an independent risk factor for coronary artery disease. In Venezuela, LPalabras claves:Apo(a), Cardiovascular disease, Lipoprotein (a), risk factorAutores:Amell A., Aparicio D., Arráiz N., Cano-Ponce C., Ciszek A., Faria J., Gotera D., Guerra-Torres X.E., Medina M.T., Mengual-Moreno E., Nuñez M., Reyna-Villasmil N., Rojas E.R., Seyfi H.A., Sorell L.T., Souki-Rincón A., Valmore Bermúdez, Velasco M.Fuentes:scopusHomeostasis model assessment (HOMA) as surrogate insulinization criteria in patients with type 2 diabetes
ArticleAbstract: Type 2 diabetes mellitus is a metabolic disorder that results from defects in both insulin secretionPalabras claves:Free fatty acids, HOMA, Insulin, Insulin Resistance, Type 2 Diabetes mellitusAutores:Acosta K., Aparicio D., Arráiz N., Bermúdez F.A., Briceño C., Bustamante M., Cabrera M., Cano R.A., Cano-Ponce C., Gómez J., Hernández-Hernandez R., Joselyn Zula, Leal E.M., Manuel V., Mengual-Moreno E., Rodriguez M., Valdelamar L., Valmore BermúdezFuentes:googlescopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusMetabolic and hemodynamic markers of endothelial dysfunction in patients with hypertension and patients with type 2 diabetes during the cold pressor test
ArticleAbstract: Leptin, a 167-amino acid peptidic hormone secreted by adipose tissue, acts mainly in the arcuate hypPalabras claves:C-Reactive protein, Hypertension, leptin, Nitric oxide, Type 2 DiabetesAutores:Arráiz N., Cano R.A., Contreras F., Fouillioux C., Lares M., Leal E.M., Valmore Bermúdez, Velasco M.Fuentes:scopusPharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopusLipoprotein (a): Molecular and Epidemiologic basis about its role in cardiovascular diseases
ReviewAbstract: In 1963, Kare Berg at the University of Oslo discovered Lp(a) as a new human plasmatic antigen set.Palabras claves:Apolipoprotein(a), Atherogenesis, Cardiovascular disease, lipoprotein(a), Lp (a), thrombogenesisAutores:Aparicio D., Arráiz N., Canelón R., Cano-Ponce C., Cizcek A., Faria J., Gotera D., Guerra-Torres X.E., Manuel V., Rojas E.R., Sorell L.T., Valmore BermúdezFuentes:scopus